Solutions 4 Wealth, Ltd
- SEC CIK
- 0002006405
- Latest filing
- Jul 29, 2026
GALT holding history
Galectin Therapeutics Inc in every 13F filed by Solutions 4 Wealth, Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GALT overviewAll 13F holders of GALTFull Q2 2026 holdings
- Shares (Q2 2026)
- 25,027
- Value
- $116.1K
- % of portfolio
- 0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 25,027 | $116.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 25,027 | $69.8K | 0.1% | −350−1.4% | Reduced | Holders |
| Q4 2025 | 25,377 | $105.6K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2025 | 25,377 | $107.5K | 0.2% | −10,626−29.5% | Reduced | Holders |
| Q2 2025 | 36,003 | $76.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 36,003 | $43.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 36,003 | $46.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 36,003 | $99.0K | 0.2% | −82−0.2% | Reduced | Holders |
| Q2 2024 | 36,085 | $81.6K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 36,085 | $86.2K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2023 | 36,085 | $59.9K | 0.2% | – | No prior filing | Holders |